Last reviewed · How we verify
Pitavastatin, Valsartan
At a glance
| Generic name | Pitavastatin, Valsartan |
|---|---|
| Also known as | Livalo, Diovan |
| Sponsor | JW Pharmaceutical |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- To Evaluate the Safety and PK Characteristics in Healthy Volunteers-Livalozet (PHASE1)
- The Occurrence of MACE in Patients With AMI Receiving Pitavastatin/Valsartan Treatment
- Clinical Study to Evaluate Adherence Improvement Fixed-dose Combination of Olostar Tab. in Patients With Hypertension and Dyslipidemia (PHASE4)
- Efficacy, Safety of Coadministered Pitavastatin and Valsartan in Patients With Hypertension and Dyslipidemia (PHASE3)
- Pharmacokinetic Study of Livalo® Fixed Combination Drug in Healthy Subjects (PHASE1)
- Drug Interaction and Safety Between Pitavastatin and Valsartan (CWP-PTV-101) (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |